Compare Aurobindo Pharma with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs BIOCON - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA BIOCON AUROBINDO PHARMA/
BIOCON
 
P/E (TTM) x 10.4 51.8 20.0% View Chart
P/BV x 3.3 7.3 45.7% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   BIOCON
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-20
BIOCON
Mar-20
AUROBINDO PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs838636 131.8%   
Low Rs281211 133.1%   
Sales per share (Unadj.) Rs394.253.1 743.0%  
Earnings per share (Unadj.) Rs48.57.5 647.5%  
Cash flow per share (Unadj.) Rs65.012.1 537.6%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs286.955.0 521.9%  
Shares outstanding (eoy) m585.931,200.00 48.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.48.0 17.8%   
Avg P/E ratio x11.556.5 20.4%  
P/CF ratio (eoy) x8.635.0 24.6%  
Price / Book Value ratio x2.07.7 25.3%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m327,872508,380 64.5%   
No. of employees `000NANA-   
Total wages/salary Rs m32,19214,588 220.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m230,98563,672 362.8%  
Other income Rs m1,9195,075 37.8%   
Total revenues Rs m232,90468,747 338.8%   
Gross profit Rs m48,38213,245 365.3%  
Depreciation Rs m9,6675,522 175.1%   
Interest Rs m3,051649 470.2%   
Profit before tax Rs m37,58212,149 309.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,1353,151 289.9%   
Profit after tax Rs m28,4478,998 316.1%  
Gross profit margin %20.920.8 100.7%  
Effective tax rate %24.325.9 93.7%   
Net profit margin %12.314.1 87.1%  
BALANCE SHEET DATA
Current assets Rs m164,12553,250 308.2%   
Current liabilities Rs m113,86840,080 284.1%   
Net working cap to sales %21.820.7 105.2%  
Current ratio x1.41.3 108.5%  
Inventory Days Days1583 18.5%  
Debtors Days Days6870 97.2%  
Net fixed assets Rs m123,50787,508 141.1%   
Share capital Rs m5866,000 9.8%   
"Free" reserves Rs m167,51859,970 279.3%   
Net worth Rs m168,10465,970 254.8%   
Long term debt Rs m012,222 0.0%   
Total assets Rs m287,632140,758 204.3%  
Interest coverage x13.319.7 67.5%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.5 177.5%   
Return on assets %11.06.9 159.8%  
Return on equity %16.913.6 124.1%  
Return on capital %24.216.4 147.7%  
Exports to sales %46.40-   
Imports to sales %15.113.3 113.5%   
Exports (fob) Rs m107,126NA-   
Imports (cif) Rs m34,9028,474 411.9%   
Fx inflow Rs m107,44511,753 914.2%   
Fx outflow Rs m38,9918,474 460.1%   
Net fx Rs m68,4543,279 2,087.6%   
CASH FLOW
From Operations Rs m43,81312,831 341.5%  
From Investments Rs m-15,676-15,589 100.6%  
From Financial Activity Rs m-19,4723,876 -502.4%  
Net Cashflow Rs m8,7121,654 526.7%  

Share Holding

Indian Promoters % 48.9 39.8 122.9%  
Foreign collaborators % 3.1 20.9 14.7%  
Indian inst/Mut Fund % 37.6 23.4 160.5%  
FIIs % 24.4 16.3 149.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 39.3 122.2%  
Shareholders   232,634 311,349 74.7%  
Pledged promoter(s) holding % 24.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   PROCTER & GAMBLE HEALTH  COMBAT DRUGS  ZIM LABORATORIES  HESTER BIOSCIENCES  CIPLA  

Compare AUROBINDO PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Recover from Day's Low to End Flat; Adani Ports and Bajaj Auto Among Top Gainers(Closing)

Indian share markets recouped early losses during closing hours and ended today's volatile session on a flat note.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

Hotel Stocks Will Reward Investors(Fast Profits Daily)

Jun 8, 2021

This is why I'm bullish on the hotel and hospitality sector.

My 'Unlock' Investments(Fast Profits Daily)

Jun 11, 2021

The best unlock investments you can make in the market.

The Most Visible Sign of India's Revival is on Two Wheels(Profit Hunter)

Jun 9, 2021

Investing in the best stocks could result in wealth compounding on a massive scale.

How I Discovered a 400-Year-Old Open Secret to Extreme Wealth(Profit Hunter)

Jun 11, 2021

Charlie Munger's open secret about investing success.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jun 18, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS